Paris, 12 October 2020
Eurazeo Patrimoine, the Eurazeo division specialising in real estate and in companies operating their own real assets, has been an investor in C2S Group since March 2018. Currently the eighth-largest operator of private clinics in France, C2S Group today announced that it has stepped up its expansion with the acquisition of four additional clinics in Franche-Comté: the Clinique Saint-Vincent and the Polyclinique de Franche-Comté in Besançon, the Clinique Saint-Pierre in Pontarlier, and the Polyclinique du Parc in Dole.

The integration of these four clinics, all leading facilities in their catchment areas, staffed by teams of recognised professionals and offering complete diagnostic and treatment services, will allow C2S Group to build up a first-rate network of clinics in Franche-Comté.

Since the acquisition of C2S in 2018, Eurazeo Patrimoine has lent its support to the Group as an active shareholder, bringing it the human and financial resources necessary for its growth, thus contributing to a twofold increase in activity in just three years, accompanied by the expansion of its network in south-east central and eastern France. The integration of five new clinics in Auxerre, Vesoul, Grenoble, Dole and Pontarlier, together with two in Besançon, all acquired over a period of less than three years, alongside the 11 facilities already being managed by C2S in 2018 when it was acquired by Eurazeo Patrimoine, has enabled the Group to increase its footprint, bringing it closer to patients and making it the leading operator of multidisciplinary clinics in the Auvergne-Rhône-Alpes and Bourgogne-Franche-Comté regions.

Thanks to the strategic vision shared by the senior executives of both C2S and Eurazeo Patrimoine, the Group has also been able to better align its business model with its values of closeness, quality, balanced medical and managerial governance, and responsible development during this growth phase.
Lastly, Eurazeo Patrimoine’s support for C2S Group has been reflected in major investment programmes: in real estate (expansion and renovation projects, creation of surgical units as well as new out-patient or emergency services) to modernise its clinics and accompany the rise in activity; in medical equipment (acquisition of surgical robots, including the first European CMR robot in operation in France) to provide the facilities and their practitioners with state-of-the-art tools and ensure an excellent standard of care for patients within their communities; and in digital technology, including the digitisation of the patient experience and a strengthened partnership with Doctolib, of which Eurazeo is a main shareholder.

Renaud Haberkorn, Head of Eurazeo Patrimoine, said:
We are very pleased to have supported C2S for nearly three years. With its recent acquisitions, the Group has taken a major step forward in its growth and in the consolidation of its leadership position in its sector at the regional level. Since 2018, Eurazeo Patrimoine’s teams have worked very closely with those at C2S Group. We are proud to be accompanying this preeminent healthcare provider in the Auvergne-Rhône-Alpes and Bourgogne-Franche-Comté regions through every step of its development.

Jean Rigondet, Chairman of C2S Group, said:
The four recently acquired clinics are all leading healthcare facilities for the Franche-Comté area, staffed by teams of talented professionals, working in a coordinated manner and with a collegial spirit, able to offer a full care pathway to patients. We are pleased that these clinics are joining the Group and that we are able to ensure a high standard of care for their communities. We aim to meet the needs of patients by providing them with top-quality healthcare services across a range of disciplines. In line with C2S Group’s continuing growth, our partnership with our shareholder Eurazeo Patrimoine, and the relationship based on attentiveness and mutual trust that we enjoy, are essential to the Group’s development.

About Eurazeo
• Eurazeo is a leading global investment company, with a diversified portfolio of €18.5 billion in assets under management, including €12.9 billion from third parties, invested in over 430 companies. With its considerable private equity, real estate and private debt expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and by offering in-depth sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.

• Eurazeo has offices in Paris, New York, São Paulo, Seoul, Shanghai, London, Luxembourg, Frankfurt, Berlin and Madrid.
• Eurazeo is listed on Euronext Paris.
• ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA

EURAZEO CONTACTS

PIERRE BERNARDIN
HEAD OF INVESTOR RELATIONS
Email: pbernardin@eurazeo.com
Tel: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT
HEAD OF COMMUNICATIONS
Email: vchristnacht@eurazeo.com
Tel: +33( 1 44 15 76 44

 

PRESS CONTACT

MAITLAND/amo
DAVID STURKEN
Email: dsturken@maitland .co .uk
Tel: +44 ( 7990 595 913